IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

BASF Sells U.S. Pharma Unit to Dr. Reddy's

2:18 AM MDT | April 30, 2008 |

Natasha Alperowicz

BASF says it has signed a definitive agreement to sell its manufacturing facility at Shreveport, LA and the related contract manufacturing business for finished pharmaceuticals to Dr. Reddy's Laboratories (Hyderabad) for an undisclosed price. The 42-acre Shreveport facility manufacutures and packages prescription and over-the-counter pharmaceutical products, liquids, tablets and creams for the North American market. BASF says it is selling the business to concentrate on core operations in the care chemicals division, which include custom synthesis services...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa